Ideal treatment for Helicobacter pylori: A systematic review

被引:8
作者
Sierra, F. [1 ,2 ]
Forero, J. D. [1 ,2 ]
Rey, M. [1 ,2 ]
机构
[1] Hosp Univ Fdn Santa Fe Bogota, Div Gastroenterol & Hepatol, Bogota, Colombia
[2] Univ Los Andes, Fac Med, Bogota, Colombia
来源
REVISTA DE GASTROENTEROLOGIA DE MEXICO | 2014年 / 79卷 / 01期
关键词
Helicobacter pylon; Eradication; Treatment; Revision; Systematic; Colombia;
D O I
10.1016/j.rgmx.2013.03.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The success rates of therapies for treating Helicobacter pylori vary greatly worldwide and the ideal treatment has yet to be clearly established. Aims: A systematic review was carried out to evaluate the effectiveness of current first and second-line therapies in treating H. pylori infection. Methods: Two researchers independently carried out Internet search engine reviews (PUBMED, EMBASE, MEDLINE) of clinical trials on adults published between 1990 and 2012 in both English and Spanish. Results: Forty-three (n = 8,123) clinical trials were evaluated that included first and second-line triple, quadruple, and sequential therapies. The eradication rates of the standard triple therapy are unacceptable (<= 80%) in countries where H. pylori is highly resistant to clarithromycin and metronidazole. Administration of the standard triple therapy for more than 7 days does not improve its effectiveness. No statistically significant differences were observed between the eradication rates of the quadruple therapy with bismuth and the standard triple therapy. Even though the sequential and concomitant therapies are equally successful regimens, the triple therapy with levofloxacin offers the best results as first and second-line treatment, but quinolone resistance can diminish its effectiveness. The triple therapy with levofloxacin and the sequential and concomitant treatments were superior to the standard triple regimen as first-line therapy. Conclusions: Currently there is no ideal first or second-line treatment for achieving 100% eradication. The therapeutic order should be carried out according to the initial treatment and local antimicrobial resistance studies. (C) 2012 Asociacian Mexicana de Gastroenterologia. Published by Masson Doyma Mexico S.A. All rights reserved.
引用
收藏
页码:28 / 49
页数:22
相关论文
共 101 条
  • [1] Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin -: Influence on treatment outcome
    Adamek, RJ
    Suerbaum, S
    Pfaffenbach, B
    Opferkuch, W
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (03) : 386 - 389
  • [2] Agudo S, 2009, REV ESP QUIM, V22, P88
  • [3] Helicobacter gastroduodenitis: A serious infectious disease - Antibiotic treatment may prevent deaths in the decades ahead
    Axon, A
    Forman, D
    [J]. BRITISH MEDICAL JOURNAL, 1997, 314 (7092) : 1430 - 1431
  • [4] Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection
    Borody, TJ
    Pang, G
    Wettstein, AR
    Clancy, R
    Herdman, K
    Surace, R
    Llorente, R
    Ng, C
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (04) : 481 - 488
  • [5] Open, randomized multicenter comparative trial of rabeprazole, ofloxacin and amoxicillin therapy for Helicobacter pylori eradication:: 7 vs. 14 day treatment
    Bosques-Padilla, FJ
    Garza-González, E
    Calderón-Lozano, IE
    Reed-SanRoman, G
    de Ariño Suárez, M
    Valdovinos-Díaz, MA
    Orozco-Gámiz, A
    Blancas-Valencia, JM
    Tamayo-de la Cuesta, JL
    [J]. HELICOBACTER, 2004, 9 (05) : 417 - 421
  • [6] Calvet X, 2000, ALIMENT PHARM THER, V14, P603
  • [7] Review article: biofilm formation by Helicobacter pylori as a target for eradication of resistant infection
    Cammarota, G.
    Sanguinetti, M.
    Gallo, A.
    Posteraro, B.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (03) : 222 - 230
  • [8] Castaño Llano Rodrigo, 2012, Rev. colomb. Gastroenterol., V27, P80
  • [9] Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapy
    Cheng, Hsiu-Chi
    Chang, Wei-Lun
    Chen, Wei-Ying
    Yang, Hsiao-Bai
    Wu, Jiunn-Jong
    Sheu, Bor-Shyang
    [J]. HELICOBACTER, 2007, 12 (04) : 359 - 363
  • [10] Treatment of Helicobacter pylori in surgical practice:: A randomised trial of triple versus quadruple therapy in a rural district general hospital
    Ching, Siok Siong
    Sabanathan, Sivakumaran
    Jenkinson, Lloyd R.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (24) : 3855 - 3860